Kimberly Brenneman, ARNP, CNM in Kalona, IA - Advanced Practice Midwife

Kimberly Brenneman, ARNP, CNM is a Advanced Practice Midwife based in Kalona, Iowa. Kimberly Brenneman is licensed to practice in Iowa (license number B170998) and her current practice location is 408 C Ave, Kalona, Iowa. She can be reached at her office (for appointments etc.) via phone at (319) 325-9348.

NPI number for Kimberly Brenneman is 1174245682 and her current mailing address is 2991 310th St, Parnell, Iowa. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1174245682.

Contact Information

	Kimberly Brenneman, ARNP, CNM
	408 C Ave, Kalona, IA 52247-9742
	(319) 325-9348
	Not Available

Provider's Profile

Full Name	Kimberly Brenneman
Gender	Female
Speciality	Advanced Practice Midwife
Location	408 C Ave, Kalona, Iowa
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1174245682
Provider Enumeration Date: 09/13/2022
Last Update Date: 09/13/2022

Medical Identifiers

Medical identifiers for Kimberly Brenneman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1174245682	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
367A00000X	Advanced Practice Midwife	B170998 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kimberly Brenneman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kimberly Brenneman, ARNP, CNM 2991 310th St, Parnell, IA 52325-8836 Ph: (319) 325-9348	Kimberly Brenneman, ARNP, CNM 408 C Ave, Kalona, IA 52247-9742 Ph: (319) 325-9348

News Archive

USPTO grants Tethys key patent for PreDx Diabetes Risk Score test

Tethys Bioscience, Inc., a privately held company, announced today that the United States Patent and Trademark Office has granted the Company US Patent 7,723,050. The patent is directed to the company's groundbreaking PreDx™ Diabetes Risk Score (DRS) test and relates to proprietary methods for assessing the risk of developing a diabetic condition.

Exposure to air pollution may contribute to blood vessel damage among young healthy adults

Fine particulate matter air pollution may be associated with blood vessel damage and inflammation among young, healthy adults, according to new research in Circulation Research, an American Heart Association journal.

Antimicrobial peptide packaged in silicon nanoparticle could combat drug-resistant bacteria

Antibiotic resistance is a growing problem, especially among a type of bacteria that are classified as "Gram-negative." These bacteria have two cell membranes, making it more difficult for drugs to penetrate and kill the cells.

Inovio to update HVTN 080 Phase I clinical study for HIV at HVTN Conference

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.

Rotavirus vaccination in babies, young children linked to slightly increased risk for intussusception

Rotaviruses are the commonest cause of diarrhea in infants and young children worldwide. To protect against rotavirus infection, in 2013 the Standing Committee on Vaccination in Germany recommended rotavirus vaccination for all infants.

Kimberly Brenneman, ARNP, CNM - Advanced Practice Midwife in Kalona, IA